Article Details

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Given Consensus Rating of "Buy" by Analysts

Retrieved on: 2021-01-16 10:07:30

Tags for this article:

Click the tags to see associated articles and topics

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Given Consensus Rating of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 1,226,284 shares of the biotechnology company's stock worth $18,063,000 after buying an additional 50,458 shares during ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up